Trial Details
ACTIVE_NOT_RECRUITINGBasic Information
| Clinical ID | c1480 |
|---|---|
| Identifier | NCT05377580 |
| Trial Title | A Study to Evaluate IBI112 in the Treatment of Moderate to Severe Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis (UC) |
| Interventions | DRUG: Period 1 IBI112 Placebo|DRUG: Period 2 IBI112 dose 3|DRUG: Period 1 IBI112 dose 1|DRUG: Period 1 IBI112 dose 2|DRUG: Period 2 IBI112 dose 4|DRUG: Period 2 IBI112 Placebo |
Participant Information
| Sponsor | Innovent Biologics (Suzhou) Co. Ltd. |
|---|---|
| City | Guangzhou |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2022-07-01 |
|---|---|
| Primary Completion Date | 2024-03-31 |
| Completion Date | 2025-09-30 |